STOCKWATCH
·
Pharmaceuticals
Deals24 May 2025, 09:30 am

Divis Laboratories Ltd. Signs Long-Term Manufacturing and Supply Agreement

AI Summary

Divis Laboratories Ltd. has entered into a long-term manufacturing and supply agreement for the production of advanced intermediates. The agreement is international in scope and the company expects meaningful revenue contribution from this deal. The cost of capacity addition for manufacturing under this agreement is estimated to be Rs.650-750 crores. The agreement will benefit the customer with assured supply and the company to expand its presence in custom synthesis.

Key Highlights

  • Divis Laboratories Ltd. has signed a long-term manufacturing and supply agreement.
  • The agreement is for the production of advanced intermediates.
  • The deal is expected to contribute significantly to the company's revenue.
  • The cost of capacity addition for manufacturing is estimated to be Rs.650-750 crores.
  • The agreement will benefit both the customer and the company.
DIVISLAB
Pharmaceuticals
DIVI'S LABORATORIES LTD.

Price Impact